Last updated 2026-07-26
TL;DR
Most Russian clinical protocols and current users dose selank intranasally in the morning or split it into two doses (morning plus early afternoon), because it's short-acting and not sedating. There's no dedicated timing study though. Evening dosing isn't dangerous, just usually pointless since effects fade in hours and won't help sleep.
what's the best time to take selank peptide, really
Short answer: morning, or morning plus early afternoon if you're splitting the daily dose. That's not a marketing line, it's just what falls out of how the peptide behaves and how the Russian studies actually dosed it. Selank is a synthetic heptapeptide (a modified fragment of tuftsin) developed in Russia, mainly by the Institute of Molecular Genetics and the V.V. Zakusov Institute of Pharmacology, and it's registered there as an anxiolytic nootropic under the brand name Selank, sold as an intranasal spray/drops [1]. It has a short half-life, animal pharmacokinetic work puts detectable peptide and its metabolites in blood and brain within minutes of intranasal dosing, with clearance over a few hours [2]. That short window is the whole reason timing matters: there's no long depot effect to plan around, so you're really deciding when you want the (modest) anxiolytic and focus effect to be active during your day. There is no dedicated human trial that compares morning versus evening versus split dosing for selank. Nobody has run that study. Everything below is inference from the pharmacokinetics, the dosing schedules used in the existing Russian trials, and patterns reported by long-term users. Treat it as an informed best guess, not settled science.
what did the actual russian studies use for dosing timing
The published Russian trials generally used twice-daily intranasal dosing, not once in the morning and not at night. A widely cited generalized anxiety disorder study used Selank at 150 micrograms per dose (roughly 0.075 mg/kg), administered intranasally, with total daily doses in the range of several hundred micrograms split across the day over a two-week course [3]. The pattern across the trials, as summarized in pharmacology reviews on Selank's mechanism and effects, is daytime dosing spread across waking hours, generally morning and afternoon or early evening, not a single nighttime dose [1][2]. None of the papers report giving selank right before sleep, and given that it's framed as an anxiolytic meant to reduce daytime anxiety without sedation, that tracks. The studies weren't testing for a sleep effect and weren't designed to answer the timing question we actually care about here, they just happened to use a schedule that avoided evening dosing. Worth being blunt about the evidence quality here: these are Russian-language trials, mostly small (often under 100 patients), run and published by researchers affiliated with the original developer institutions, and none have been independently replicated in a Western academic or FDA-regulated trial setting [1][3]. That doesn't make the data worthless, the pharmacology and behavioral work is genuinely detailed and spans decades, but it does mean you're relying on evidence that hasn't been through the kind of adversarial replication that Western regulators and journals demand. If you want the fuller picture on what that evidence actually contains, the selank overview breaks down the study list in more depth.
morning vs splitting into two doses, which should you actually pick
If you're using selank for daytime anxiety or focus, morning dosing (or morning plus a second dose 4 to 6 hours later) is the more defensible choice, mostly because that's what the human trials modeled and because the effect window is short. Here's the practical logic. Selank's behavioral and biochemical effects in animal and early human work show up within roughly 30 to 60 minutes of intranasal dosing and don't appear to last much beyond a few hours [2]. If you take it once at 7am, you're likely not getting meaningful effect by mid-afternoon. That's the whole argument for splitting: one dose to cover the morning stretch, a second dose around midday or early afternoon to cover the rest of the workday. Single morning dosing makes sense if your anxiety or focus demand is front-loaded, morning meetings, a stressful commute, or you just want to test how it feels before committing to a twice-daily habit. Splitting makes sense if your day is long and you want coverage without the effect tapering off by 2pm. Neither is proven better in a trial, but the split schedule mirrors what the actual GAD study did more closely [3]. For exact microgram ranges and how people typically titrate up, that's covered in detail on the selank dosage page rather than repeated here.
should you take selank at night or before bed
Generally, no, and not because it's dangerous, but because it's the wrong tool for that job. Selank isn't a sedative and isn't marketed or studied as a sleep aid. Its profile in the Russian literature is anxiolytic without the sedation, motor impairment, or dependence liability seen with benzodiazepines, which was actually one of the selling points researchers highlighted when comparing it to diazepam in animal anxiety models [2]. That non-sedating profile is exactly why an evening dose is usually a waste. If it's not making you drowsy, it's not going to help you fall asleep, and since its effects clear within a few hours, taking it at 10pm mostly just means you're asleep before it would have done anything useful anyway. Some users report that reduced background anxiety in the evening indirectly helps them settle down, but that's an anecdotal secondary effect, not a documented sleep mechanism. If anxiety is specifically keeping you up at night, that's a different problem than what these trials tested, and selank isn't the peptide built for it. Worth flagging here for anyone conflating the two: semax, selank's sibling peptide from the same Russian research lineage, has a more stimulating, nootropic-forward profile and is even less suited to evening use. The distinctions matter enough that we've written a full comparison at semax vs selank if you're trying to figure out which one actually fits your goal.
does taking selank on an empty stomach or with food change anything
Nobody has published data on this specifically for selank, and honestly it's a smaller variable than route of administration. Selank is dosed intranasally in essentially all the clinical literature, not orally, so stomach contents and food timing are largely irrelevant to absorption in the way they'd matter for a swallowed capsule [1][2]. What actually matters more: intranasal delivery bypasses the gut entirely, that's the reason this route was chosen for a peptide, since oral bioavailability for peptides this size is typically very poor due to enzymatic breakdown in the digestive tract. So "take with food" advice that applies to a lot of supplements just doesn't map onto how selank is used in the literature. If you're using an injectable form instead of intranasal (some users do, though the Russian trials are intranasal), food timing is even less relevant since you're bypassing digestion altogether. For anyone comparing intranasal spray against subcutaneous injection as a delivery method, that tradeoff (convenience versus cost versus consistency) is covered on the selank semax injection page.
can you take selank and semax at the same time, and does timing change
People do stack them, and when they do, the more common pattern reported is semax in the morning (for its more stimulating, focus-forward reputation) and selank later, or split across the day, for the calming effect without cutting into the semax activation. But there's no clinical trial on the combination, so this is user-reported pattern, not established protocol. Semax and selank come from the same Russian peptide research lineage (both linked to work out of the Institute of Molecular Genetics and the Zakusov Institute) but they're chemically distinct: semax is derived from ACTH fragments, selank from tuftsin, and their studied effects diverge, semax leaning nootropic/stimulating, selank leaning anxiolytic [1][2]. Conflating them, or assuming timing advice for one applies cleanly to the other, is a common mistake. If you're trying to sort out which peptide (or which combination) actually matches what you want, selank vs semax walks through the mechanism differences in more detail than fits here. Given the total lack of dedicated stacking trials, if you're going to combine them, the more conservative move is to test each one alone first at your intended dose and time before combining, so you actually know which peptide is responsible for which effect (or side effect).
what happens if you miss a dose or take it at a random time
Nothing dramatic. Selank doesn't appear to build up a steady-state blood level the way a daily SSRI does, its effects are described as acute and short-lived rather than cumulative across days, based on the pharmacokinetic data showing clearance within hours [2]. Missing a dose doesn't trigger withdrawal in the trial data, and there's no tapering protocol described in the Russian clinical literature for stopping it. That said, the actual GAD trial ran as a defined course, two weeks of twice-daily dosing, not an indefinite as-needed regimen [3]. If you're trying to replicate what was actually studied, consistency across the day (not skipping the second dose) matters more than hitting an exact clock time. Taking it at 9am one day and 11am the next is very unlikely to matter. Skipping the second daily dose entirely for a week, then wondering why effects feel inconsistent, is a much more plausible explanation for perceived unreliability.
how does the evidence quality here compare to a typical FDA-reviewed drug
This is the section that matters most if you're deciding whether to trust any of this timing advice at all, so it's worth being direct about it. Selank is approved and sold as a prescription-adjacent anxiolytic in Russia, where it went through that country's own regulatory registration process [1]. That is not the same thing as FDA approval, and it hasn't gone through an FDA New Drug Application review, a Phase 3 US trial, or independent replication published in a major Western psychiatry or neurology journal. In the US, selank is sold as a research chemical, not as an approved drug or a legal supplement for human consumption, and it isn't FDA-approved for any use [4]. The Russian trials that do exist, the GAD study, various animal behavioral pharmacology papers, some smaller human anxiety and cognition studies, are real, published, and in some cases show a plausible dose-response and a comparison against reference drugs like diazepam [2][3]. That's more than you get with most gray-market research chemicals. But sample sizes are small, blinding and randomization details aren't always reported to Western journal standards, and there's no independent Western group that has replicated the core anxiolytic claims in a peer-reviewed trial as of this writing. That combination, real but thin, Russian-only, unreplicated, is the single most important thing to understand before you decide when (or whether) to take this at all.
how selank co and pharmacy partners handle sourcing and timing guidance
Selank Co reviews provider sourcing and compounding pharmacy partnerships rather than manufacturing or compounding anything itself, so the practical timing guidance above reflects what's in the published literature and reported user patterns, not a proprietary protocol. If you've decided you want to try selank after weighing the evidence gaps above, the more responsible path than an unregulated research-chemical vendor is a provider-reviewed route through a licensed compounding pharmacy, where dosing, purity, and administration guidance come from people who actually have to answer for it. That's a meaningfully different risk profile than a gray-market vial with no chain of custody. For a broader look at how the peptide is studied and where the gaps are, see the selank evidence overview.
quick reference: timing scenarios and what the evidence actually supports
| Scenario | What the evidence supports | Confidence | |
|---|---|---|---|
| Morning single dose | Matches typical anxiolytic-use pattern; effect window a few hours | Low-moderate, inferred from PK data [2] | |
| Split AM + early PM | Mirrors twice-daily dosing used in the GAD trial | Moderate, matches published protocol [3] | |
| Evening/bedtime dose | Not studied for sleep; non-sedating profile means limited rationale | Low, contradicts non-sedating mechanism [2] | |
| With or without food | Irrelevant for intranasal route; no oral bioavailability data | Not applicable to studied route [1][2] | |
| Combined with semax | User-reported stacking pattern only | No clinical data either way | The table above is really just the article compressed. Nothing in it is a hard rule, because nobody has run the trial that would make it one. |
Frequently asked questions
What is the best time of day to take selank peptide?
Morning is the most commonly used timing, either as a single dose or the first of two daily doses. This matches the twice-daily schedule used in the published Russian GAD trial and fits selank's short, non-sedating effect window of a few hours [3][2]. There's no dedicated timing trial though, so this is inference, not a proven optimal schedule.
Can I take selank before bed to help me sleep?
It's not built for that. Selank is studied as a non-sedating anxiolytic, meaning it doesn't cause drowsiness, so an evening dose is unlikely to help you fall asleep and its effects clear within hours anyway [2]. If anxiety is disrupting your sleep specifically, that's outside what the existing trials tested.
How many times a day should I take selank?
The main published clinical trial used twice-daily intranasal dosing over a two-week course, roughly morning and afternoon [3]. Once-daily morning dosing is also common among current users who want a simpler routine, but that pattern hasn't been separately tested against the twice-daily protocol.
Does selank need to be taken with food?
No. Selank is dosed intranasally in essentially all the clinical literature, not swallowed, so food timing (which matters for oral absorption) doesn't really apply. There's no published data suggesting food affects intranasal peptide absorption for selank specifically [1][2].
Is selank the same as semax, and does timing advice overlap?
No, they're chemically distinct peptides from the same Russian research lineage. Semax comes from ACTH fragments and leans nootropic/stimulating; selank comes from tuftsin and leans anxiolytic [1][2]. Timing advice doesn't transfer cleanly between them; see semax vs selank for the mechanism-level comparison.
What happens if I miss a dose of selank?
Nothing dramatic based on available data. Selank clears from the body within hours and doesn't appear to build steady-state levels or cause withdrawal, unlike a daily SSRI [2]. Missing a single dose just means you miss that day's effect window, not a rebound or tapering issue.
Is Russian approval of selank the same as FDA approval?
No, and this distinction matters. Selank is registered as an anxiolytic in Russia through that country's own regulatory process [1]. It has not gone through FDA review, has no FDA-approved indication, and is sold in the US as a research chemical, not an approved drug or supplement [4].
Can I stack selank and semax, and in what order during the day?
Some users report semax in the morning for focus and selank later or split through the day for calm, but this stacking pattern comes from user reports, not a clinical trial. Testing each peptide alone first, at your intended dose, is the more conservative approach before combining them.
How long does a single dose of selank last?
Based on pharmacokinetic data from animal and early human studies, effects appear within roughly 30 to 60 minutes of intranasal dosing and taper off within a few hours, since selank clears from blood and brain tissue relatively quickly [2]. This short window is why many protocols use two doses across a day rather than one.
Is there a study that specifically tested morning vs evening dosing of selank?
No. As of this writing there's no published trial comparing dosing times for selank. All timing guidance, including in this article, is inferred from the drug's short half-life, its non-sedating anxiolytic profile, and the twice-daily daytime schedule used in the existing Russian clinical trials [2][3].
Why is most of the selank research in Russian and not replicated in Western trials?
Selank was developed by Russian institutions (the Institute of Molecular Genetics and the Zakusov Institute of Pharmacology) and its clinical trials were run and published there, largely in Russian-language journals [1]. No major Western academic center has independently replicated the core anxiolytic findings in a peer-reviewed trial as of this writing, which is a real limitation, not a minor caveat.
Should I buy selank from a research chemical vendor or a pharmacy?
A provider-reviewed route through a licensed compounding pharmacy carries more accountability for dosing accuracy and purity than an unregulated research-chemical vendor, where there's often no verifiable chain of custody. Selank Co reviews these provider and pharmacy options rather than manufacturing or compounding anything itself.
Sources
- Kolomin T, Shadrina M, Slominsky P, et al. "A New Strategy for the Development of Drugs Acting on the Basis of Regulatory Peptides," Acta Naturae, 2014, PMC4207533: Selank was developed by Russian institutions and is registered there as an anxiolytic nootropic intranasal peptide
- Kolomin T, Shadrina M, Andreeva LA, et al., "Selank Elicits Long-Lasting Antidepressant Effect via Modulation of BDNF Expression," PMID 25233603: Selank's pharmacokinetics show rapid brain penetration after intranasal dosing and a short, non-sedating effect window compared to diazepam in animal models
- Zozulya AA, Neznamov GG, Siniagin AB, et al., clinical study of Selank in generalized anxiety disorder, PMC3181997: Published Russian clinical trial used twice-daily intranasal Selank dosing (150 mcg per dose) over a two-week course for generalized anxiety disorder
- U.S. Food and Drug Administration, Drugs@FDA database, application search for products containing "selank": Selank has no FDA-approved indication and does not appear in the FDA's approved drug products database
- Volkova A, Shadrina M, Kolomin T, et al., "Selank Administration Affects Gene Expression of Neurotransmitter Systems in Rat Brain," PMID 26824793: Selank's behavioral effects in animal models involve modulation of gene expression in neurotransmitter systems, consistent with rapid brain penetration after intranasal dosing
- Medvedeva ES, Dmitrieva VG, Povarnina PY, et al., "Effects of Selank on the Rat Brain Transcriptome," PMID 30447045: Peer-reviewed pharmacology work on Selank's mechanism has continued to be published, largely by the same Russian research groups, without independent Western replication